Consulting in clinical drug safety, pharmacovigilance, and medical product epidemiology since 1988!

The Degge Group, Ltd., A PharmaLex Company

Located just outside WASHINGTON DC, The Degge Group, a PharmaLex Company, provides consulting services to the biopharmaceutical and medical products sector specializing in clinical drug safety, pharmacovigilance, medical product epidemiology, and risk management.

Degge's staff has contributed to the burgeoning fields of pharmacoepidemiology and pharmacovigilance for over two decades and has worked to enhance the understanding of drug safety, drug use, natural history of disease studies, risk evaluation and mitigation strategies (REMS), benefit-risk assessments, and pharmacoeconomic and outcomes research.

Degge will help you identify and analyze key data to meet your needs.



Judith K Jones, MD, PhD,FISPE, President of The Degge Group, Ltd. (a PharmaLex company), spoke at the International Society for Pharmacoepidemiology’s 10th Annual Asian Conference on Pharmacoepidemiology (ACPE) in Brisbane, Australia, October 29-31, 2017. She presented her views on the promise and pitfalls of Big Data on Sunday, October 29.

Degge was a Gold Sponsor (and Exhibitor) for the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 26 – 30, 2017 in Montreal, Canada.

Our Poster Presentations:
  • Degge Poster, Aug 28th - Testing the Validity of Comparative Reproductive Tract Cancer Rates Combining Two Methods of Subject Identification in a Large Cohort Study of Rural Northern Vietnamese Women
  • DGI/B.R.I.D.G.E. TO DATA® Poster, Aug 30th - Challenges and Solutions for Globally Establishing and Standardizing Population Healthcare Databases

As of April 24, 2017, The Degge Group, Ltd. has become a member of PharmaLex GmbH (Friedrichsdorf, Germany), an international consortium of small companies similar to Degge but with different areas of scientific expertise and focus in the biopharma industry. We are pleased about joining PharmaLex’s group of companies. The impact of Degge’s joining PharmaLex will primarily be felt in our Research and Regulatory Consulting Divisions, which will be enhanced by additional PharmaLex expertise and services. Read More

Our recent publication: Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations was recently published in Journal of Pain. Coauthors included Shannon M Smith and Judith K Jones, MD, PhD, FISPE.

Contact Us

The Degge Group, Ltd.
9302 Lee Highway, Suite 700
Fairfax, VA 22031 USA
P: +1 (571) 490-8020
F: +1 (571) 490-8408
S: LinkedIn
O: Online Form

 Degge Crest



      Risk Management /
      Risk Evaluation &
      Mitigation Strategies


Pharmacoepidemiology Research


Pharmacoeconomic and Outcomes Research




Regulatory Affairs - US and International


Oversight Group Management

SBIR Grants

      Government Grants


Regulatory Medical-Legal

For scientific support in medico-legal affairs please contact Degge's Senior Legal Services Manager through our online form.


Graduate Internship Program

© 2018 The Degge Group Ltd., All Rights Reserved

Icons made by Freepik, Designmodo and is licensed by CC BY 3.0